9 rezultatima
FIELD OF THE INVENTION
The present invention generally relates to the field of creatine, and particularly to an anti-inflammatory creatine compound.
BACKGROUND OF THE INVENTION
The treatment of inflammation and the pain, swelling, fever, and the like, associated with inflammation using
FIELD OF THE INVENTION
The present invention generally relates to the field of creatine, and particularly to an anti-inflammatory creatine compound.
BACKGROUND OF THE INVENTION
The treatment of inflammation and the pain, swelling, fever, and the like, associated with inflammation using
BACKGROUND OF INVENTION
The present invention refers to a composition composed of a cetylated fatty acid and alkali buffered creatine for reducing joint and muscle related inflammation.
Chronic inflammation and muscle pain affects the body's ability to execute fluid motion. Ensuing joint stiffness
BACKGROUND
The emu (Dromiceius novae-hollandiae) is the second largest member of the group of flightless birds and is indigenous to Australia. Emus can be raised like ordinary farm animals and used for their valuable products, which include very low fat meat, supple leather hides, decorative and
FIELD OF THE INVENTION
The present invention relates to a new method of use for creatine compounds such as creatine kinase inhibitors and, more particularly, cyclocreatine, to block intracellular signals of the thrombin receptor Protease Activated Receptor-1, to thereby inhibit thrombin-induced
BACKGROUND OF THE INVENTION
This invention relates to compositions and methods for normalizing impaired or deteriorating neurological function in humans. More particularly, this invention relates to compositions and methods which use a holistic approach for normalizing impaired or deteriorating
FIELD OF THE INVENTION
This invention relates to a method for inhibiting apoptosis in ischemic-reperfused myocardium. More specifically this invention relates to a method for using heparin or noncoagulant heparin in the prevention of apoptosis.
BACKGROUND OF THE INVENTION
Cells die by one of either
RELATED APPLICATIONS
This application is a .sctn.371 application from PCT/EP2008/000501 filed Jan. 23, 2008 which claims priority from Germany Patent Application No. 10 2007 004 781.0 filed Jan. 31, 2007, each of which is herein incorporated by reference in its entirety.
DESCRIPTION
The present
CROSS-REFERENCES TO RELATED APPLICATIONS
This application is a national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/CN2014/080938, filed on Jun. 27, 2014, which claims the priority of Chinese patent application Serial No. 201310572068.2 filed with the State